Table of Contents
1. Identification
Summary
Fructose is a ketohexose monosaccharide (C₆H₁₂O₆). It exists predominantly as furanose/pyranose hemiketals in solution and serves as a dietary sugar and endogenous metabolite in human carbohydrate metabolism.
Brand Names
Not applicable.
Name
Fructose (D-fructose)
Background
Naturally present in fruits, honey, and sucrose (as the fructosyl moiety). Principal intestinal transporter GLUT5; hepatic entry into glycolytic/gluconeogenic pathways via ketohexokinase (fructokinase).
Modality
Small molecule (monosaccharide)
Groups
Nutrient; endogenous metabolite; food ingredient
Structure
Weight
~180.16 g/mol
Chemical Formula
C₆H₁₂O₆
Synonyms
D-Fructose; Levulose; β-D-fructofuranose; α/β-D-fructopyranose
External IDs
CAS: 57-48-7; PubChem CID: 5984; UNII: 6YSS42VSEV
2. Pharmacology
Indication
Not a therapeutic drug. Nutrient/sweetener; metabolic substrate.
Associated Conditions
Dietary carbohydrate metabolism; hereditary disorders include essential fructosuria (KHK deficiency) and hereditary fructose intolerance (ALDOB deficiency).
Associated Therapies
None (nutrient context).
Contraindications & Blackbox Warnings
None applicable (not a drug). Clinical cautions derive from specific inborn errors of metabolism and dietary management.
Pharmacodynamics
Enters intermediary metabolism after phosphorylation → fructose-1-phosphate (KHK) or fructose-6-phosphate (hexokinase, minor in most tissues) → glycolysis/gluconeogenesis.
Mechanism of action
Biochemical substrate: intestinal GLUT5 uptake → portal circulation (GLUT2) → hepatic KHK phosphorylation → aldolase B cleavage to dihydroxyacetone phosphate and glyceraldehyde.
Absorption
Predominantly via GLUT5 (SLC2A5) in enterocytes; facilitated diffusion.
Volume of distribution
Distributes in total body water; rapid hepatic extraction.
Protein binding
Negligible.
Metabolism
Hepatic phosphorylation (KHK) and cleavage (ALDOB) to triose phosphates; interconversion with glucose via gluconeogenesis/glycolysis.
Route of elimination
Metabolized to CO₂ and water; carbon shunted to glycogen, lipids, or glucose depending on nutritional state.
Half-life
Short (minutes) in circulation post-absorption due to rapid hepatic uptake.
Clearance
High hepatic clearance (first-pass).
Adverse Effects
Nutrient-level effects depend on dose and context; clinical toxicity pertains to inherited enzyme deficiencies.
Toxicity
In hereditary fructose intolerance, fructose/ sucrose/ sorbitol ingestion causes F-1-P accumulation with hypoglycemia and hepatic/renal injury.
Pathways
Intestinal GLUT5 → GLUT2 export; hepatic KHK (F-1-P) → ALDOB → triose phosphates.
Pharmacogenomic Effects/ADRs
Pathogenic variants in KHK (essential fructosuria) and ALDOB (HFI) alter handling/tolerance.
3. Interactions
Drug Interactions
None specific at therapeutic-drug level; co-ingested nutrients/hormonal milieu modulate downstream metabolic routing.
Food Interactions
Occurs within mixed meals; absorption enhanced with co-ingested glucose (shared transport/export).
4. Categories
ATC Codes
None.
Drug Categories
Monosaccharide; Nutrient; Carbohydrate
Chemical Taxonomy
Ketohexose; predominantly furanose/pyranose cyclic hemiketals in aqueous solution.
Affected organisms
Humans (nutrient/metabolite)
5. Chemical Identifiers
UNII
6YSS42VSEV
CAS number
57-48-7
InChI Key
BJHIKXHVCXFQLS-FUTKDDECSA-N
InChI
InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2
IUPAC Name
(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one
SMILES
C(C(C(C(C(=O)CO)O)O)O)O
6. References
PubChem Compound Summary — D-(−)-Fructose (CID 5984); formula C₆H₁₂O₆, MW ~180.16, synonyms and identifiers. PubChem
NIST Chemistry WebBook — CAS 57-48-7; InChIKey BJHIKXHVCXFQLS-FUTKDDECSA-N; cyclic/linear form note. webbook.nist.gov+1
FDA GSRS/UNII — Fructose UNII 6YSS42VSEV registry entry. gsrs.ncats.nih.gov
StatPearls — Fructose metabolism overview: GLUT5 absorption; ketohexokinase (fructokinase) pathway; hepatic handling. NCBI
Peer-review/Annual Reviews — regulatory updates in glucose/fructose metabolism. annualreviews.org
Supplier/Nomenclature refs — linear SMILES and IUPAC name for D-fructose. Fisher Scientific

I am pursuing MBA in pharmaceutical management from NIPER Hyderabad with a strong academic record and proven success in national-level pharmacy entrance exams. I secured AIR 61 in NIPER 2024 (MS/M.Pharm) and AIR 27 in NIPER MBA, along with AIR 147 in GPAT 2024 and AIR 907 in GPAT 2023. I also achieved AIR 6 in AIIMS CRE-2025 for Drug Store Keeper and was selected as a Pharmacist (AIR 61) for ESIC. Additionally, I was the Runner-Up in Round 2 of the EY Case Study Competition.
At PharmacyFreak.com, I aim to guide future pharmacists through expert content, exam strategies, and insightful resources based on real experience and academic excellence.
Mail- harsh@pharmacyfreak.com